Navigation Links
Elekta receives US FDA 510(k) clearance for its Monaco 5 treatment planning system
Date:11/27/2013

ATLANTA, Nov. 27, 2013 /PRNewswire/ -- Monaco® 5, the latest version of Elekta's Monaco treatment planning system has received 510(k) clearance from the US Food & Drug Administration, making it available for purchase and use in the United States.

"Monaco 5 consolidates the best of Elekta's treatment planning solutions into one system, increasing confidence and clinical versatility for the radiation oncology team," says Todd Powell, Executive Vice President of Elekta Software. "Its new system architecture allows advanced treatment plans to be created faster than ever."

Monaco now supports the full spectrum of radiotherapy techniques, including VMAT, IMRT and 3D conformal radiation therapy. The system is especially well equipped for sophisticated stereotactic therapies, such as SRS and SRT, with added planning support for specialized beam shaping solutions, including circular cones. As in all Monaco releases, the new version employs the Monte Carlo dose engine, considered the gold standard for calculating radiation dose.

Clinicians at Union Hospital's HUX Cancer Center (Terre Haute, Indiana) have been evaluating the non-clinical alpha version of Monaco 5 for several months.

"Monaco 5 gives us a single point where all of our planning can be completed, regardless of whether we prepare stereotactic, electron, IMRT, VMAT or 3D plans. From a workflow standpoint it's a huge improvement," says Michele Verst, MS, HUX's chief medical physicist. "In addition, the Monaco 5 user interface is more intuitive than previous versions – everything is nicely organized. For example, if you want to do contouring, you click on the contour tab and all your tools are right there. The icons are a nice size and clearly visible. From usability, workflow and data management perspectives, Monaco 5 gives us tremendous benefits."

Learn more at www.elekta.com/Monaco5.

For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.andersson@elekta.com  
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
2. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
3. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
4. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
5. U.K. Cancer Patient is Worlds First to Benefit from Treatment Combining Elektas New Beam-shaping Innovation and High-speed Arc Therapy
6. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
7. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
8. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
9. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
10. Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
11. Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):